Estimating the Cost of COVID-19 Treatment for U.S. Private Insurers
Executive Summary
The COVID-19 pandemic has had an extraordinary, unprecedented, and severe impact on virtually all aspects of life in the United States. As significant an impact as the virus has already had in several countries around the world, and in several states, the potential impact of the continued virus proliferation on our health care system could be immense. Given the potential for broad infection and a significant increase in associated hospitalizations in the United States, America’s Health Insurance Plans (“AHIP”) retained Wakely Consulting Group (“Wakely”) to explore the potential COVID-19 testing and treatment cost implications to U.S. private insurers for 2020 and 2021.
Read the full report below